Showing results (81-90 of 87) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Hepatology (Baltimore, Md.)|April 11, 2012
Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humansJames Pritchett, Emma Harvey, Varinder Athwal, et al.Journal of Hepatology|April 29, 2014
IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infectionMohammed Eslam, Reynold Leung, Manuel Romero-Gomez, et al.Frontiers in Oncology|December 25, 2023
Preclinical evidence for anaplastic lymphoma kinase inhibitors as novel therapeutic treatments for cholangiocarcinomaKyaw Zwar Myint, Mireia Sueca-Comes, Pamela Collier, et al.Gastro Hep Advances|August 21, 2024
Promoter Methylation Leads to Hepatocyte Nuclear Factor 4A Loss and Pancreatic Cancer AggressivenessMaria Hatziapostolou, Marina Koutsioumpa, Abed M Zaitoun, et al.Cancer Research and Treatment|October 19, 2020
Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma CellsBoonyakorn Boonsri, Kiren Yacqub-Usman, Pakpoom Thintharua, et al.EMBO Molecular Medicine|November 8, 2017
SOX9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosisVarinder S Athwal, James Pritchett, Jessica Llewellyn, et al.European Review for Medical and Pharmacological Sciences|November 2, 2023
Utilization of direct oral anticoagulants in a Saudi tertiary hospital: a retrospective cohort studyH Sultan, M AlNasser, A Assiri, et al.Pageof 9